FAVApp
- El Salvador
- Nonprofit
Children and adolescents with cancer living in Low-and-middle Income Countries (LMICs) continue to have lower cure rates than those living in High-Income Countries (HICs) due to inequalities in scientific, technological, and therapeutic advances in pediatric cancer care. In LMICs, only around 20% of children with cancer can be cured, compared to HICs where more than 80% of cases reach a cure. In the region of Latin America and the Caribbean 29,057 new cases are diagnosed yearly, representing 10.4% of all cases of pediatric cancer globally.
El Salvador is a low and middle-income country where only 20% of the population has health insurance. The remaining 80% are covered by the Ministry of Health. The demand for health coverage is high, given that approximately 44% of the nation is aged 0-19 years old. The National Childhood Cancer Program receives 200 new patients yearly. Survival rates have increased from 5% in 1994 to 70% in 2020 and treatment is free of charge for patients. El Salvador´s pediatric cancer program is a level 2 cancer center, within a tertiary pediatric hospital. Aside from medical and treatment appointments, cancer patients also travel to the hospital when treatment complications arise.
Multiple factors contribute to low cure rates in LMICs. Misdiagnosis and delayed diagnosis, socioeconomic difficulties, inadequate supportive care, treatment abandonment, death from toxicity, and difficulty accessing care all contribute to lower cure rates. Violence, poverty, and long distances further complicate access to treatment in Central American countries.
Education and communication between healthcare providers and caregivers of children with cancer are crucial to guaranteeing the best care possible for children with cancer in LMICs. When children with cancer are home, caregivers are responsible for making decisions. When emergencies arise at home, most patients consult at primary and secondary healthcare centers near their homes for treatment-related complications and are transferred to the tertiary care hospital. However, primary and secondary care centers lack the knowledge and expertise to treat the complexities of pediatric cancer patients, resulting in delayed care for potentially life-threatening conditions. Approximately 10% of patients in treatment die from treatment-related complications, which can be decreased through proper leadership and supervision.
FAVApp will be usable by caregivers offering information and patients´ personal clinical information and for health care professionals with access to patient information, self-report measures for better symptom management as well as being able to provide telemedicine to caregivers and communication to offer professional assistance to public healthcare providers to manage symptoms locally and decrease patient´s unnecessary travel to the hospital and reduce patient mortality.
The introduction of initiatives like FAVApp can potentially address some challenges by improving communication between healthcare providers and caregivers, offering better symptom management through self-report measures, and providing telemedicine services to reduce unnecessary hospital visits and mortality rates.
Here are some key points and suggestions based on the information provided:
Improving Access to Care: Given that many patients in LMICs have to travel long distances to access care, telemedicine can play a crucial role in providing remote consultations and support. Movimiento Amarillo can facilitate this by offering telemedicine services to caregivers, allowing them to consult healthcare professionals without the need for travel.
Enhancing Education and Communication: Educating both healthcare providers and caregivers about pediatric cancer is vital for early diagnosis and proper management. FAVApp can serve as a platform for sharing information and resources, providing educational materials for caregivers, and facilitating communication between caregivers and healthcare professionals.
Symptom Management: Providing tools for better symptom management through self-report measures can help caregivers monitor the child's condition and report any concerning symptoms promptly. This can lead to early intervention and potentially reduce treatment-related complications and mortality rates.
Support for Primary and Secondary Healthcare Centers: Since primary and secondary healthcare centers often lack the expertise to treat pediatric cancer patients, FAVApp can offer support and guidance to healthcare providers in these settings. This can include remote consultations with specialists, access to treatment protocols, and assistance in managing treatment-related complications.
Data Management and Patient Privacy: It's essential to ensure that FAVApp complies with data protection regulations and safeguards patient privacy and confidentiality. This includes implementing secure data storage practices, obtaining informed consent from patients and caregivers, and adhering to relevant laws and regulations.
Overall, initiatives like FAVAPp have the potential to make a significant impact on improving outcomes for children with cancer in LMICs like El Salvador. By addressing the challenges of access to care, education, and communication, such platforms can help bridge the gap in pediatric cancer care between low- and high-income countries.
El Salvador is the smallest country in Central America, with a land area of 20,721 km2. The country has registered persistently low economic growth levels due to violence and poverty. According to the International Monetary Fund, GDP per Capita is equal to $ 9,139.70 per year. The publication entitled "Projections and Estimates of the Population of El Salvador (1950-2050)", produced by the Ministry of Economic and General Office of Statistics and Censuses, reports the projection of El Salvador's total population for the year 2020 of 6,765,935 inhabitants. The pediatric population (0-18 years) constitutes 35%.
El Salvador´s National Childhood Cancer Program, supported by Ayúdame a Vivir Foundation in alliance with Children National Hospital Benjamin Bloom and St. Jude Children's Research Hospital, was established in 1993. Since its beginnings, the program has sought access to comprehensive treatment for Salvadoran children with cancer, improving their quality of life and their families in all stages of the disease. The program has national coverage of pediatric cancer and receives 200 new childhood cancer cases annually and treats 350 patients per year in an age range of 0-<18 years. Treatment is free of charge for patients, but the disease incurs in out-of-pocket expenses, like travel allowance. Leukemia (48%) is the most frequent pediatric cancer in our community, followed by Lymphomas (13%) and Central Nervous System Tumors (12%). The treatment for patients can last a minimum of nine months to a maximum of two years and a half. According to socioeconomic interviews, 51% of our pediatric cancer population lives in extreme poverty and 49% of our patients live within a sustainable economy. 75% of children with cancer in El Salvador have to travel between 2-12 hours to reach the hospital.
Progress in childhood cancer treatment has resulted in survival rates of over 80% in High-income Countries (HIC). The reality is different in low and middle-income countries, where approximately 80% of children with cancer are diagnosed but only 20% are cured. In El Salvador, cure rates are 65%. Abandonment of treatment rates in low and middle-income countries is high due to poverty, lack of access to treatment, and socioeconomic factors. El Salvador has an abandonment of treatment rate of less than 1% due to the team's efforts in education and communication.
The team intends to focus now on maximizing the benefits of technology and making alliances with primary and secondary attention healthcare providers. We have wanted to create our app for caregivers and patients for many years, primarily to provide more education on cancer treatments and the management of side effects and complications. With a cancer diagnosis, comes a lot of information and responsibilities for caregivers to manage. From appointments, medicines, side effects, and the hospital routine, caregivers need guidance with information. The national pediatric cancer program educates caregivers from the point of diagnosis on specialized topics to provide ongoing care for these children. Education includes diagnosis and treatment, teaching specialized skills for at-home care, and assessing potential life-threatening complications that require immediate medical intervention.
The team's commitment to supporting patients and their families throughout the cancer continuum, from diagnosis to survivorship or end-of-life care, demonstrates a deep understanding of the holistic needs of patients and their families.
Here are some key strengths and aspects of the team's approach:
Comprehensive Care Model: The team's approach extends beyond medical treatment to encompass psychological and emotional support, as well as long-term follow-up care. This holistic model recognizes the diverse needs of patients and families and emphasizes continuity of care throughout the cancer journey.
Multidisciplinary Collaboration: The collaboration among various professionals, including oncologists, psychologists, nurses, and members of the board of directors, ensures a comprehensive and well-rounded approach to problem-solving and decision-making. This multidisciplinary approach allows for diverse perspectives and expertise to be integrated into the development of solutions.
Adaptability and Innovation: The successful implementation of telemedicine during the pandemic highlights your team's adaptability and willingness to embrace innovative solutions to enhance the quality of care. By leveraging technology, the team has been able to overcome barriers to access and provide timely support to patients and families, even from a distance.
Community Engagement: The team's strong relationships with patients, families, and supporters create a sense of community with a shared goal of improving outcomes for pediatric cancer patients. This collaborative approach fosters trust, engagement, and a supportive environment for all stakeholders involved.
Long-term Vision: The long-standing idea of developing an application for patients and providers reflects your team's forward-thinking approach to leveraging technology to enhance education, communication, and support. By recognizing the importance of addressing patients' needs beyond the hospital setting and embracing technological solutions, the team has demonstrated a commitment to continuous improvement and innovation in pediatric cancer care.
Overall, the team's dedication, collaboration, and innovative spirit are instrumental in advancing the quality of care and quality of life for children and adolescents with cancer. By prioritizing the holistic needs of patients and families and embracing technology as a tool for improvement, the team is making a significant impact in the field of pediatric oncology.
- Increase access to and quality of health services for medically underserved groups around the world (such as refugees and other displaced people, women and children, older adults, and LGBTQ+ individuals).
- 3. Good Health and Well-Being
- 5. Gender Equality
- 10. Reduced Inequalities
- 17. Partnerships for the Goals
- Prototype
Currently, the only version of the app that has been developed is the adherence module. This module is aimed at children and adolescents with cancer and includes functions that tackle the multiple dimensions of adherence. Through games, patients are encouraged to send daily videos to the team while taking their oral medication on camera and showing the pill wrapping. Initial testing supports the idea that all functions work fairly well. An initial version (1.0) has been tested by a group of families in Android mobile devices for UI and UX. Our communications team is working on a roll-out campaign. Our warehouse has a supply of toys for variable ages to be used as prizes. The prize scheme has already been developed by the psychology team. Processes to ensure proper data input are already written and support staff is ready. At this time, we are seeking funding to be able to upload FAVapp at major app stores (PlayStore and App Store).
We have already passed the concept stage of exploring the idea and have verified that the module is socially acceptable, sustainable, and may have a positive effect on survival. For the development of this stage, we did research consisting of individual interviews and focus groups with patients.
Fundación Ayúdame a Vivir, has ambitious goals for the FAVApp and recognizes the importance of securing funding, onboarding users, addressing technical challenges, and scaling the app effectively. Here are some suggestions and strategies for addressing each of these areas:
Financial Barriers:
- Develop a comprehensive funding proposal that clearly articulates the need for financial support to cover subscription costs, storage, additional staff, and ongoing maintenance of the PediOnc app. Highlight the potential impact of the app on pediatric cancer care and patient outcomes to attract potential investors and funders.
- Explore various sources of funding, including grants from philanthropic organizations, corporate sponsorships, partnerships with healthcare institutions or pharmaceutical companies, and individual donations. Tailor your pitch to each potential funder's priorities and interests.
Onboarding:
- Collaborate with SOLVE to connect with experts who can help promote the FAVApp within the pediatric cancer community and increase adoption among families and healthcare providers. Leverage their expertise in community engagement and user outreach to effectively onboard new users and drive usage.
Technical Challenges:
- Partner with technical consultants and experts in AI and app development to enhance the capabilities of the FAVApp and address scalability issues. Collaborate with these professionals to implement AI-driven features for medication identification and automate processes for appointment scheduling, medication management, and patient data handling.
- Continuously monitor and evaluate the technical performance of the app, identifying areas for improvement and optimization to ensure proper functionality and user experience.
Scaling:
- Develop a strategic plan for scaling the FAVApp to other pediatric cancer programs in low and middle-income countries. Identify key target regions and institutions where the app could have the greatest impact and prioritize outreach and partnership efforts accordingly.
- Provide training and support for new users and program leaders to facilitate the successful implementation and integration of the FAVApp into existing healthcare systems. Offer customization options to tailor the app to the specific needs and preferences of different program settings, ensuring maximum relevance and effectiveness.
- Establish mechanisms for ongoing communication and collaboration with partner organizations, fostering a network of support and sharing best practices for app utilization and program management.
By addressing these key areas strategically and collaboratively, your organization can overcome challenges and successfully scale the FAVApp app to improve pediatric cancer care globally.
- Business Model (e.g. product-market fit, strategy & development)
- Financial (e.g. accounting practices, pitching to investors)
- Monitoring & Evaluation (e.g. collecting/using data, measuring impact)
- Technology (e.g. software or hardware, web development/design)
Psychooncologist